ClavystBio

Funding rounds backed by ClavystBio.

Export CSV
Funding disclosed in full
$70.4M
Median round
$35.2M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Leyden Laboratories

Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses

€40MSeries BBiotechNetherlands
4 participantsClavystBioEuropean Innovation Council (EIC) FundGates FoundationInvest-NL
Rejoni

Develops a hydrogel system to treat uterine health conditions and prevent scarring

$25MSeries AHealthtechUnited States
8 participantsAmed VenturesAscension VenturesCatalyst Health VenturesClavystBioDelos CapitalFemHealth VenturesIyengar CapitalSparta Group